EP3810089
VATNSSAMSETNING SEM INNIHELDUR 1-(4-{[4-DÍMETÝLAMÍNÓ)PÍPERIDÍN-1-ÝL]KARBONÝL}FENÝL)-3-[4-(4,6-DÍMORFÓLÍN-4-ÝL-1,3,5-TRÍASÍN-2-ÝL)FENÝL]ÞVAGEFNI
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
4.6.2019EP published:
2.8.2023EP application number:
19742898.0
EP translation filed:
1.9.2023Grant published:
15.11.2023EPO information:
European Patent Register
Max expiry date:
3.6.2039Expiry date:
3.6.2026Next due date:
30.6.2026
Title in English:
AQUEOUS FORMULATION COMPRISING 1-(4-{[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]CARBONYL}PHENYL)-3-[4-(4,6-DIMORPHOLIN-4-YL-1,3,5-TRIAZIN-2-YL)PHENYL]UREALanguage of the patent:
English
Timeline
Today
4.6.2019EP application
2.8.2023EP Publication
1.9.2023Translation submitted
15.11.2023Registration published
3.6.2026Expires
Owner
Name:
Pfizer Inc.Address:
66 Hudson Boulevard East, New York, NY 10001-2192, US
Inventor
Name:
HUSSEY, James JosephAddress:
Sandwich Kent CT13 9NJ, GB
Name:
BRIGHT, Andrew GilbertAddress:
Sandwich Kent CT13 9NJ, GB
Agent
Name:
Tego IP ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
201862681722 PDate:
7.6.2018Country:
US
Number:
201862754651 PDate:
2.11.2018Country:
US
Number:
201962796133 PDate:
24.1.2019Country:
US
Number:
201962841882 PDate:
2.5.2019Country:
US
Classification
Categories:
A61K 9/00, A61K 9/08, A61K 9/19, A61K 31/5377, A61K 47/12, A61K 47/40, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 21.5.2024
Expires: 3.6.2025
Payer: Árnason Faktor ehf.
Number: 7
Paid: 2.6.2025
Expires: 3.6.2026
Payer: Árnason Faktor ehf.